Equifax (EFX) Competitors $264.20 +0.12 (+0.05%) Closing price 03:59 PM EasternExtended Trading$262.06 -2.14 (-0.81%) As of 07:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock EFX vs. CCRN, CRAI, FI, G, IQV, IT, OMC, RHI, TRU, and WMShould you be buying Equifax stock or one of its competitors? The main competitors of Equifax include Cross Country Healthcare (CCRN), Charles River Associates (CRAI), Fiserv (FI), Genpact (G), IQVIA (IQV), Gartner (IT), Omnicom Group (OMC), Robert Half (RHI), TransUnion (TRU), and Waste Management (WM). Equifax vs. Its Competitors Cross Country Healthcare Charles River Associates Fiserv Genpact IQVIA Gartner Omnicom Group Robert Half TransUnion Waste Management Cross Country Healthcare (NASDAQ:CCRN) and Equifax (NYSE:EFX) are both business services companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, media sentiment, analyst recommendations, dividends, risk, institutional ownership and valuation. Which has more volatility and risk, CCRN or EFX? Cross Country Healthcare has a beta of 0.36, suggesting that its stock price is 64% less volatile than the S&P 500. Comparatively, Equifax has a beta of 1.6, suggesting that its stock price is 60% more volatile than the S&P 500. Do institutionals and insiders hold more shares of CCRN or EFX? 96.0% of Cross Country Healthcare shares are held by institutional investors. Comparatively, 96.2% of Equifax shares are held by institutional investors. 4.9% of Cross Country Healthcare shares are held by company insiders. Comparatively, 1.4% of Equifax shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Which has stronger earnings & valuation, CCRN or EFX? Equifax has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Equifax, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCross Country Healthcare$1.34B0.31-$14.56M-$0.53-24.11Equifax$5.68B5.78$604.10M$4.8954.03 Is CCRN or EFX more profitable? Equifax has a net margin of 10.68% compared to Cross Country Healthcare's net margin of -1.41%. Equifax's return on equity of 18.81% beat Cross Country Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Cross Country Healthcare-1.41% 2.56% 1.84% Equifax 10.68%18.81%7.60% Do analysts recommend CCRN or EFX? Cross Country Healthcare currently has a consensus target price of $17.93, suggesting a potential upside of 40.30%. Equifax has a consensus target price of $295.19, suggesting a potential upside of 11.73%. Given Cross Country Healthcare's higher possible upside, analysts plainly believe Cross Country Healthcare is more favorable than Equifax.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cross Country Healthcare 0 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Equifax 0 Sell rating(s) 6 Hold rating(s) 12 Buy rating(s) 1 Strong Buy rating(s) 2.74 Does the media prefer CCRN or EFX? In the previous week, Equifax had 10 more articles in the media than Cross Country Healthcare. MarketBeat recorded 12 mentions for Equifax and 2 mentions for Cross Country Healthcare. Equifax's average media sentiment score of 1.39 beat Cross Country Healthcare's score of 0.51 indicating that Equifax is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cross Country Healthcare 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Equifax 9 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryEquifax beats Cross Country Healthcare on 15 of the 17 factors compared between the two stocks. Get Equifax News Delivered to You Automatically Sign up to receive the latest news and ratings for EFX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding EFX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EFX vs. The Competition Export to ExcelMetricEquifaxConsulting IndustryBusiness SectorNYSE ExchangeMarket Cap$32.80B$7.81B$13.08B$20.52BDividend Yield0.76%1.63%2.71%3.76%P/E Ratio54.0325.8128.6227.79Price / Sales5.782.9939.7640.48Price / Cash20.5818.1726.6222.26Price / Book6.806.236.234.58Net Income$604.10M$272.15M$188.58M$982.91M7 Day Performance0.11%3.11%3.78%1.31%1 Month Performance-1.66%0.34%4.13%4.85%1 Year Performance9.49%1.84%37.53%14.09% Equifax Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EFXEquifax4.907 of 5 stars$264.20+0.0%$295.19+11.7%+9.1%$32.80B$5.68B54.0314,700Positive NewsAnalyst ForecastHigh Trading VolumeCCRNCross Country Healthcare3.8543 of 5 stars$13.05+2.0%$17.93+37.4%-5.1%$427.78M$1.34B-24.628,205CRAICharles River Associates3.1276 of 5 stars$187.37+0.2%$228.00+21.7%+14.8%$1.28B$687.41M25.29940Analyst UpgradeFIFiserv4.8019 of 5 stars$172.290.0%$221.23+28.4%+15.2%$95.52B$20.46B30.4441,000Positive NewsGGenpact3.2281 of 5 stars$44.02+1.1%$50.71+15.2%+48.4%$7.70B$4.85B15.02140,000IQVIQVIA4.897 of 5 stars$157.69+0.1%$226.32+43.5%-21.9%$27.28B$15.41B21.4886,000ITGartner4.7564 of 5 stars$403.99+0.3%$515.89+27.7%-11.7%$31.10B$6.30B25.1419,500OMCOmnicom Group4.9316 of 5 stars$72.03+0.9%$96.43+33.9%-17.0%$14.05B$15.69B9.8574,900Positive NewsUpcoming EarningsRHIRobert Half4.9501 of 5 stars$41.06-0.6%$48.71+18.6%-34.9%$4.19B$5.67B20.5314,700Positive NewsTRUTransUnion4.6243 of 5 stars$88.05+0.9%$109.69+24.6%+20.1%$17.18B$4.18B46.8413,400Positive NewsAnalyst UpgradeWMWaste Management4.8233 of 5 stars$228.92+0.3%$251.00+9.6%+7.8%$92.12B$22.06B34.5349,500 Related Companies and Tools Related Companies Cross Country Healthcare Alternatives Charles River Associates Alternatives Fiserv Alternatives Genpact Alternatives IQVIA Alternatives Gartner Alternatives Omnicom Group Alternatives Robert Half Alternatives TransUnion Alternatives Waste Management Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:EFX) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | Sponsored$3,200 from your phone?No charts. No crypto. No stock picking. With just a regular brokerage app and Jeff Clark’s “Crossfire” meth...TradeSmith | SponsoredElon brings 'disruption and chaos ' to DCWhat it's really like to work with Elon... "A business partner of mine has close ties to the Department of ...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Equifax, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Equifax With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
